Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring molecular changes in the management of myelodysplastic syndromes.

British journal of haematology - 1 Sept 2024

Duployez Nicolas, Preudhomme Claude

Abstract excerpt

The ongoing or anticipated therapeutic advances as well as previous experience in other malignancies, including acute myeloid leukaemia, have made molecular monitoring a potential interesting tool for predicting outcomes and demonstrating treatment efficacy in patients with myelodysplastic syndromes (MDS). The important genetic heterogeneity in MDS has made challenging the establishment of recommendations. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Management
Share to High-Throughput Nucleotide Sequencing
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 38934371
DOI: 10.1111/bjh.19614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring molecular changes in the management of myelodysplastic syndromes.PMID 38934371Read ↗

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Semantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read ↗

Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.Semantic proximity Read ↗

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaSemantic proximity Read ↗

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencingSemantic proximity Read ↗

Myelodysplastic Syndrome: Diagnosis and ScreeningSemantic proximity Read ↗

Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.Semantic proximity Read ↗

Mutational profiling in patients with MDS: ready for every-day use in the clinic?Semantic proximity Read ↗

Clonal evolution in myelodysplastic syndromes.Semantic proximity Read ↗

The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.Semantic proximity Read ↗

New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.